Pulmonx Welcomes Two New Board Members, Adding Expertise in Health Technology, Consumer Marketing, and Integrated Healthcare Delivery Networks
August 02, 2021 08:45 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG), a global leader in minimally invasive treatments for severe lung disease, welcomes Alissa Hsu Lynch and...
Pulmonx to Present at the Canaccord Genuity 41st Annual Growth Conference
July 29, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx to Report Second Quarter 2021 Financial Results on August 3, 2021
July 20, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Zephyr® Valve Treatment Provides Long-Term Quality of Life and Lung Function Improvements for Patients with Severe COPD/Emphysema
May 17, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced that key...
Pulmonx Reports First Quarter 2021 Financial Results
May 04, 2021 16:02 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for severe lung disease,...
Pulmonx Corporation Expands Leadership Team
May 04, 2021 16:01 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx to Present at BofA Securities 2021 Virtual Health Care Conference
April 27, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for lung disease, today announced the company...
Pulmonx to Report First Quarter 2021 Financial Results on May 4, 2021
April 20, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Reports Fourth Quarter and Full Year 2020 Financial Results
March 02, 2021 16:01 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
February 16, 2021 16:01 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...